We are live on
!
Find out more
AG
Aperio Group Portfolio holdings
AUM
$33.8B
1-Year Est. Return
31.46%
This Fund
S&P 500
This Quarter
Est. Return
+9.4%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.02%
10 Year Est. Return
–
AUM
$27.8B
AUM Growth
+$2.54B
(+10%)
Cap. Flow
+$477M
Cap. Flow
% of AUM
1.71%
Top 10 Holdings %
Top 10 Hldgs %
17.19%
Holding
2,397
New
92
Increased
1,264
Reduced
960
Closed
73
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$37.3M |
| 2 |
Johnson & Johnson
JNJ
|
+$35.5M |
| 3 |
Verizon
VZ
|
+$26.4M |
| 4 |
Truist Financial
TFC
|
+$26.1M |
| 5 |
CTXS
Citrix Systems Inc
CTXS
|
+$18.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$53.1M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$25.3M |
| 3 |
CHL
China Mobile Limited
CHL
|
+$16.9M |
| 4 |
CUK
Carnival PLC
CUK
|
+$15M |
| 5 |
WBK
Westpac Banking Corporation
WBK
|
+$14.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.1% |
| 2 | Financials | 16.78% |
| 3 | Healthcare | 13.34% |
| 4 | Consumer Discretionary | 9.48% |
| 5 | Communication Services | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EVBG
2026
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $324K | ﹤0.01% |
4,149
+403
| +11% | +$31.1K |
|
|
OPTU
2027
Optimum Communications Inc
OPTU
$290M
| $323K | ﹤0.01% |
+11,794
| New | +$326K |
|
2028
Travere Therapeutics
TVTX
$5.33B
| $323K | ﹤0.01% |
22,747
+7,822
| +52% | +$99.9K |
|
|
SAVE
2029
DELISTED
Spirit Airlines, Inc.
SAVE
| $323K | ﹤0.01% |
8,015
+369
| +5% | +$14K |
|
|
CCXI
2030
DELISTED
ChemoCentryx, Inc.
CCXI
| $323K | ﹤0.01% |
8,179
-6,352
| -44% | -$112K |
|
2031
Caesars Entertainment
CZR
$6.03B
| $322K | ﹤0.01% |
5,396
-853
| -14% | -$42.2K |
|
2032
Lattice Semiconductor
LSCC
$17.7B
| $322K | ﹤0.01% |
16,800
-1,073
| -6% | -$20.6K |
|
|
SWCH
2033
DELISTED
Switch, Inc. Class A Common Stock
SWCH
| $322K | ﹤0.01% |
21,699
+1,358
| +7% | +$20.6K |
|
|
CKH
2034
DELISTED
Seacor Holdings Inc.
CKH
| $322K | ﹤0.01% |
7,453
-4,886
| -40% | -$214K |
|
2035
Moderna
MRNA
$23B
| $321K | ﹤0.01% |
+16,430
| New | +$291K |
|
2036
Mercantile Bank Corp
MBWM
$1.03B
| $320K | ﹤0.01% |
8,780
-298
| -3% | -$10.5K |
|
2037
Element Solutions
ESI
$8.68B
| $319K | ﹤0.01% |
27,281
-4,742
| -15% | -$52.3K |
|
2038
Universal Insurance Holdings
UVE
$1.23B
| $318K | ﹤0.01% |
11,352
-633
| -5% | -$18.3K |
|
|
SLCA
2039
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $317K | ﹤0.01% |
51,559
+7,298
| +16% | +$44K |
|
|
CSFL
2040
DELISTED
CenterState Bank Corporation Common Stock
CSFL
| $317K | ﹤0.01% |
12,703
-703
| -5% | -$17.6K |
|
|
MTSC
2041
DELISTED
MTS Systems Corp
MTSC
| $317K | ﹤0.01% |
6,606
-159
| -2% | -$8.45K |
|
|
FSB
2042
DELISTED
Franklin Financial Network, Inc.
FSB
| $316K | ﹤0.01% |
9,193
-1,066
| -10% | -$35.1K |
|
2043
NETGEAR
NTGR
$616M
| $315K | ﹤0.01% |
12,837
+48
| +0.4% | +$1.31K |
|
2044
Veracyte
VCYT
$4.77B
| $315K | ﹤0.01% |
11,283
-287
| -2% | -$7.43K |
|
2045
AtriCure
ATRC
$2.04B
| $313K | ﹤0.01% |
9,619
+902
| +10% | +$25.7K |
|
|
LGF.A
2046
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $313K | ﹤0.01% |
29,386
+14,478
| +97% | +$133K |
|
2047
National Beverage
FIZZ
$3B
| $312K | ﹤0.01% |
12,206
-632
| -5% | -$15.2K |
|
2048
Orion
OEC
$381M
| $312K | ﹤0.01% |
+16,172
| New | +$292K |
|
|
VIVO
2049
DELISTED
Meridian Bioscience Inc
VIVO
| $312K | ﹤0.01% |
31,858
+7,263
| +30% | +$68.2K |
|
2050
Children's Place
PLCE
$54.3M
| $308K | ﹤0.01% |
4,933
-357
| -7% | -$26K |
|
Similar funds
OU
CTA
GAM
CCI
SWM
LCM
HCMNY
BII
Aperio Group's Q4 2019 Portfolio in Review
As of Q4 2019, Aperio Group held 2,397 positions worth $27.8B, up 10% from $25.3B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Aperio Group's Q4 2019 filing shows 92 new, 1,264 increased, 960 reduced and 73 closed positions. Its largest new stake was Cerence: 67,887 shares worth $1.54M. The largest sale was Celgene Corp, an estimated $53.1M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- Aperio Group's largest Q4 2019 buy was Cerence: 67,887 shares worth $1.54M.
- Aperio Group added most to Bristol-Myers Squibb in Q4 2019, an estimated $37.3M increase.
- Aperio Group's biggest Q4 2019 reduction was China Mobile Limited, cutting an estimated $16.9M.
- Aperio Group fully exited Celgene Corp in Q4 2019, selling an estimated $53.1M.
- Aperio Group's ten largest holdings make up 17% of its $27.8B portfolio in Q4 2019.
- Aperio Group opened 92 new positions and closed 73 in Q4 2019.
- Aperio Group's portfolio value rose 10% quarter-over-quarter to $27.8B.
Based on Aperio Group's 13F filing for Q4 2019, filed 13 Feb 2020.